Skip to main content
. 2013 Apr 30;346:f2450. doi: 10.1136/bmj.f2450

Table 1.

 Association between diagnostic variables and pneumonia in 2820 patients presenting with acute cough in primary care. Figures are numbers (percentages) unless mentioned otherwise

Diagnostic variable Missing Total (n=2820) Pneumonia present (n=140, 5%) OR (95% CI) P value
Univariable Multivariable*
History (day 1)
Mean (SD) age (years) 0 (0.0) 50 (17) 54 (15) 1.1 (1.0 to 1.2)† 1.1 (0.9 to 1.2)† 0.118
Men 0 (0.0) 1128 (40) 62 (44) 1.2 (0.9 to 1.7) NA
Current smoker 2 (0.1) 779 (28) 64 (30) 1.1 (0.8 to 1.5) NA
Mean (SD) No of days’ illness before consultation 30 (1.1) 10 (10) 9 (6) 1.0 (0.9 to 1.0) NA
Cough 2 (0.1) 2818 (100) 140 (100) 0.1 (0.0 to 0.8) NA
Severe cough 0 931 (33) 56 (40) 1.4 (1.0 to 2.0) 1.1 (0.7 to 1.6) 0.724
Phlegm 2 (0.1) 2239 (79) 120 (86) 1.6 (1.0 to 2.6) NA
Breathlessness 1 (0.0) 1594 (57) 96 (69) 1.7 (1.2 to 2.5) 1.4 (1.0 to 2.1) 0.025
Severe breathlessness 0 197 (7) 17 (12) 1.9 (1.1 to 3.4) 1.3 (0.7 to 2.4) 0.419
Runny nose absent 1 (0.0) 808 (29) 61 (44) 2.0 (1.4 to 2.8) 1.9 (1.3 to 2.7) <0.001
Fever 3 (0.1) 989 (35) 82 (59) 2.8 (2.0 to 3.9) NA
Chest pain 3 (0.1) 1304 (46) 80 (57) 1.6 (1.1 to 2.2) 1.2 (0.8 to 1.7) 0.402
Severe chest pain 0 141 (5) 13 (9) 2.1 (1.2 to 4.0) 1.5 (0.8 to 3.1) 0.224
Diarrhoea 2 (0.1) 199 (7) 15 (11) 1.6 (0.9 to 1.8) 1.5 (0.8 to 1.8) 0.165
Interference with daily activities 1 (0.0) 1759 (62) 96 (69) 1.3 (0.9 to 1.9) NA
Any comorbidity (pulmonary, cardiac, diabetes mellitus)‡ 4 (0.1) 768 (27) 50 (36) 1.5 (1.1 to 2.2) 1.0 (0.7 to 1.5) 0.960
Physical examination (day 1)
General toxicity 5 (0.2) 739 (26) 43 (31) 1.3 (0.9 to 1.8) 1.1 (0.7 to 1.6) 0.728
Diminished vesicular breathing 15 (0.5) 362 (13) 31 (22) 2.0 (1.3 to 3.1) 1.7 (1.1 to 2.6) 0.013
Crackles 13 (0.5) 265 (9) 45 (32) 5.3 (3.6 to 7.7) 3.5 (2.3 to 5.2) <0.001
Tachycardia (pulse >100 beats/min) 36 (1.3) 111 (4) 17 (12) 3.8 (2.2 to 6.6) 2.3 (1.3 to 4.3) 0.003
Tachypnoea (>24 breaths/min) 67 (2.4) 55 (2) 6 (4) 2.4 (1.0 to 5.7) 1.4 (0.9 to 2.0) 0.421
Blood pressure <90/60 mm Hg 58 (2.1) 71 (3) 9 (6) 2.9 (1.4 to 5.9) NA
Temperature >37.8°C 27 (1.0) 158 (6) 22 (16) 3.5 (2.1 to 5.7) 2.5 (1.4 to 4.4) <0.001
Blood test results (day 1)
CRP (mg/L):
 Mean (SD) 142 (5.0) 19 (35) 69 (83) 1.2 (1.1 to 1.2)§ 1.1 (1.1 to 1.2)§ <0.001
 >20 142 (5.0) 726 (26) 85 (61) 4.9 (3.5 to 7.0) 3.5 (2.4 to 5.0) <0.001
 >30 142 (5.0) 501 (18) 74 (53) 5.9 (4.2 to 8.4) 3.8 (2.7 to 5.5) <0.001
 >50 142 (5.0) 255 (9) 58 (41) 8.9 (6.2 to 12.9) 4.8 (3.2 to 7.1) <0.001
 >100 142 (5.0) 96 (3) 34 (24) 13.5 (8.5 to 21.5) 6.0 (3.6 to 10.0) <0.001
Procalcitonin (µg/L):
 Mean (SD) 156 (5.5) 0.09 (0.6) 0.37 (2.6) 1.2 (1.1 to 1.3)¶ 1.2 (1.1 to 1.3)¶ <0.001
  >0.25 156 (5.5) 107 (6) 20 (14) 2.8 (1.7 to 4.6) 2.2 (1.3 to 3.8) <0.001
  >0.50 156 (5.5) 78 (3) 14 (10) 4.5 (2.5 to 8.3) 3.2 (1.7 to 6.3) <0.001

NA=not analysed.

*Variables entered in model, based on literature: age, breathlessness, runny nose, chest pain, diarrhoea, comorbidity (pulmonary, cardiac, or diabetes), general toxicity, diminished vesicular breathing, crackles, tachycardia, tachypnoea, temperature >37.8°C. Both backward and forward selection showed same results. ORs after internal validation are shown.

†Per 10 years.

‡Pulmonary comorbidity=history of asthma or COPD (chronic obstructive pulmonary disease). Cardiac comorbidity=history of heart failure or ischaemic heart disease.

§Per 10 mg/L increase.

¶Per 0.10 µg/L increase.